Skin disorders

Jun 21, 2016 by in PHARMACY Comments Off on Skin disorders

 ointments, which are greases such as white or yellow soft paraffin. They are more occlusive on the skin than creams, and this keeps the skin hydrated,  pastes, which are suspensions…

read more

Cerebrovascular disease and dementia

Jun 21, 2016 by in PHARMACY Comments Off on Cerebrovascular disease and dementia

 primary prevention of a first event (ischaemic or haemorrhagic stroke),  prevention of recurrence of stroke or of other cardiovascular events,  rehabilitation after the stroke. About one-third of strokes are recurrent….

read more

Anxiolytics, sedatives and hypnotics

Jun 21, 2016 by in PHARMACY Comments Off on Anxiolytics, sedatives and hypnotics

Fig. 20.1 The GABAA receptor.The GABAA receptor consists of five transmembrane subunits configured from the 19 possible subunits that have been identified; thus many configurations of the GABA receptor exist,…

read more

General anaesthetics

Jun 21, 2016 by in PHARMACY Comments Off on General anaesthetics

Drugs are used in combination to produce the appropriate balance of sedation, analgesia and muscle relaxation while minimising unwanted effects; at particular doses and concentrations, each contributes minor or major…

read more

Peripheral vascular disease

Jun 21, 2016 by in PHARMACY Comments Off on Peripheral vascular disease

 Diarrhoea.  Headache.  Palpitation and tachycardia.  Other PDE3 inhibitors such as milrinone have been shown to decrease survival in people with heart failure (Ch. 7); cilostazol does not appear to increase…

read more

Constipation, diarrhoea and irritable bowel syndrome

Jun 21, 2016 by in PHARMACY Comments Off on Constipation, diarrhoea and irritable bowel syndrome

 opioid analgesics (this chapter and Ch. 19)  antimuscarinic agents, e.g. oxybutynin (Ch. 15), orphenadrine (Ch. 24), cyclizine (Ch. 32)  antacids containing calcium or aluminium salts (Ch. 33)  calcium channel blockers…

read more

Drug discovery, safety and efficacy

Jun 21, 2016 by in PHARMACY Comments Off on Drug discovery, safety and efficacy

 The administration of controlled amounts of the purified active compound removed biological variability in the potency of the crude plant preparation.  The administration of the active component removed the unwanted…

read more

Dyspepsia and peptic ulcer disease

Jun 21, 2016 by in PHARMACY Comments Off on Dyspepsia and peptic ulcer disease

 non-erosive reflux disease,  erosive oesophagitis, an acute inflammatory T-helper cell 1 (Th1) response (Ch. 38),  Barrett’s oesophagus (intestinal metaplasia of oesophageal mucosal cells) with increased risk of cancer; this is…

read more

Migraine and other headaches

Jun 21, 2016 by in PHARMACY Comments Off on Migraine and other headaches

 unilateral pain,  throbbing,  aggravation on movement,  pain of moderate or severe intensity, and one of the following:  nausea or vomiting,  light or noise sensitivity (photophobia or phonophobia). Pathogenesis of migraine…

read more
Get Clinical Tree app for offline access